- C96.29 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM C96.29 became effective on October 1, 2022.
- This is the American ICD-10-CM version of C96.29 – other international versions of ICD-10 C96.29 may differ.
ICD-10-CM C96.29 is grouped within Diagnostic Related Group(s):
- 011 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with mcc
- 012 Tracheostomy for face, mouth and neck diagnoses or laryngectomy with cc
- 013 Tracheostomy for face, mouth and neck diagnoses or laryngectomy without cc/mcc
- 820 Lymphoma and leukemia with major o. R. Procedures with mcc
- 821 Lymphoma and leukemia with major o. R. Procedures with cc
- 822 Lymphoma and leukemia with major o. R. Procedures without cc/mcc
- 823 Lymphoma and non-acute leukemia with other procedures with mcc
- 824 Lymphoma and non-acute leukemia with other procedures with cc
- 825 Lymphoma and non-acute leukemia with other procedures without cc/mcc
- 840 Lymphoma and non-acute leukemia with mcc
- 841 Lymphoma and non-acute leukemia with cc
- 842 Lymphoma and non-acute leukemia without cc/mcc
Code History
- 2018 (effective 10/1/2017): New code
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to C96.29:
- specified type NEC > malignant C96.20
- malignant > Mastocytoma (extracutaneous) D47.09
- malignant > Mastocytosis D47.09
- specified type NEC > malignant mast cell C96.20